Gentian Diagnostics presents at DNB conference in New York

05. Dec 2019 | 1 min read

Moss 05.12.19
The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the DNB Nordic American Life Science conference in New York. Please find the presentation attached.

For further information, please contact

Hilja Ibert CEO, Gentian Diagnostics AS
E-mail: hilja.ibert@gentian.no 
+47 919 05 242

Njaal Kind CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no 
+47 919 06 525

You may also read


Jul 02, 2026 - Ole Sørlie

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

Jun 24, 2026 - Ole Sørlie

ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

May 29, 2026 - Ole Sørlie

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..